Literature DB >> 3493746

Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients.

E Lebovics, M Palmer, J Woo, F Schaffner.   

Abstract

The natural history and prognostic factors of primary sclerosing cholangitis (PSC) are poorly defined. We reviewed our experience with PSC to determine its natural history and whether any factors on presentation or during follow-up were indicative of a favorable or unfavorable prognosis. Thirty-eight patients were followed up for 75.1 +/- 58.7 months; 17 (45%) had a poor outcome, defined as the occurrence of death (11 patients [29%]), variceal hemorrhage, hepatic encephalopathy, or hepatic transplantation. We found the following: the rate of progression of PSC is highly variable; an asymptomatic presentation may not indicate a more favorable outcome or prolonged survival; a serum bilirubin value of four times or more the upper limit of normal, particularly if sustained so as to exclude a reversible cause, is indicative of late-stage disease with a likelihood of subsequent poor outcome and death; and variceal hemorrhage may occur before the terminal stage of the disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493746

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Aetiology and natural history of primary sclerosing cholangitis--a decade of progress?

Authors:  R W Chapman
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

Review 3.  The evolution of natural history of primary sclerosing cholangitis.

Authors:  Will R Takakura; James H Tabibian; Christopher L Bowlus
Journal:  Curr Opin Gastroenterol       Date:  2017-03       Impact factor: 3.287

4.  Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis.

Authors:  M Seo; M Okada; S Osamura; S Hara; T Umeno; K Maeshiro; Y Yamada; K Yuh
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

5.  Primary sclerosing cholangitis associated with systemic sclerosis.

Authors:  G Fraile; J L Rodríguez-García; A Moreno
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

6.  Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis.

Authors:  K M Abu-Elmagd; M Malinchoc; E R Dickson; J J Fung; P A Murtaugh; A L Langworthy; A J Demetris; R A Krom; D H Van Thiel; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1993-10

7.  Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods.

Authors:  M Lombard; M Farrant; J Karani; D Westaby; R Williams
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

8.  Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis.

Authors:  J S Gavaler; B Delemos; S H Belle; A E Heyl; R E Tarter; T E Starzl; C Gavaler; D H van Thiel
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.